Trials / Completed
CompletedNCT00761202
Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the performance and acceptance of Optive versus Hylocomod eyedrops, when administered for one month to patients with mild to moderate dry eye symptoms, with and without contact lenses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | A sterile solution containing sodium carboxymethylcellulose and glycerin, preserved with PURITE® | Eyedrops as required, but at least 3 times per day |
| DRUG | Sodium hyaluronate | Eyedrops as required, but at least 3 times per day |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2008-09-29
- Last updated
- 2013-11-19
- Results posted
- 2010-02-04
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00761202. Inclusion in this directory is not an endorsement.